ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Makes First NRS Award – 13 Institution Grants; 150 Individuals Pending: Lepovetsky Training Chief

April 4, 1975

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

November 26, 2014

NCI Remains Exception To NIH Authority Over Scientific Counselors

January 27, 1995

Harold Varmus Plans To Leave Presidency Of MSKCC

January 15, 2010

ODAC Oks Carboplatin As 1st Line Ovarian Therapy; Other Drugs

July 12, 1991

Two Doses of the Vaccine Cervarix Can Be As Effective As Three

September 30, 2011